Remove 2016 Remove Atrial Fibrillation Remove Outcomes
article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S.

article thumbnail

Comparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure

Journal of the American Heart Association

BackgroundAn increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. 0.45] for rivaroxaban), and a 69% to 83% reduced risk of net composite outcomes (aHR, 0.25 [95% CI, 0.18–0.35] We identified 3759 patients with DOAC failure. 0.41] for rivaroxaban).ConclusionsIn

article thumbnail

Combination of early rhythm control and healthy lifestyle on the risk of stroke in elderly patients with new-onset atrial fibrillation: a nationwide population-based cohort study

Frontiers in Cardiovascular Medicine

Background The impact of early rhythm control (ERC) combined with healthy lifestyle (HLS) on the risk of ischemic stroke in elderly patients with atrial fibrillation (AF) remains unaddressed. Objective To evaluate the impact of combined ERC and HLS on the risk of stroke in elderly patients with new-onset AF.

article thumbnail

Abstract 4135095: Outcomes of Atrial Fibrillation Patients with Thrombocytopenia: Insights From a Nationwide Database

Circulation

Background:While anticoagulation is crucial for atrial fibrillation (AF) patients to prevent ischemic events, those with thrombocytopenia have a potential increased risk of bleeding. The primary outcome was all-cause inpatient mortality.

article thumbnail

Abstract TP230: Atrial Fibrillation and Short-Term Outcomes After Cancer-Related Ischemic Stroke

Stroke Journal

Introduction:Atrial fibrillation (AF) and cancer are both independently associated with worse outcomes in patients with acute ischemic stroke. Few studies have evaluated the impact of AF on outcomes of cancer-related stroke. The primary outcome was in-hospital mortality. The primary exposure was a diagnosis of AF.

Cancer 40
article thumbnail

Effectiveness, utilisation and cost associated with implantable loop recorders versus external monitors after ischaemic or cryptogenic stroke

Open Heart

Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes.

Stroke 73
article thumbnail

Abstract 4142533: Ventricular rate of Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention and the Risk of Adverse Outcomes

Circulation

Background:Atrial fibrillation (AF) often coexists with acute coronary syndromes (ACS) or conditions requiring percutaneous coronary interventions (PCI), worsening the outcome. Circulation, Volume 150, Issue Suppl_1 , Page A4142533-A4142533, November 12, 2024.